Peptides for Fat Loss & Metabolic Optimization

Beyond Diet: Peptides That Target Fat Metabolism

While GLP-1 agonists dominate weight loss headlines, several other peptides target fat metabolism and body composition through completely different mechanisms — growth hormone pathways, mitochondrial activation, and direct lipolysis. These compounds are particularly interesting for body recomposition (losing fat while maintaining or gaining lean mass), which GLP-1s alone don't optimize for.

AOD-9604 — The GH Fragment for Fat

AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) that retains GH's fat-metabolizing properties without its growth-promoting or diabetogenic effects. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) through a mechanism independent of the GH receptor.

• Targeted lipolysis: Stimulates fat breakdown without the full GH hormonal cascade
• No GH side effects: Does not raise IGF-1, does not cause insulin resistance or water retention
• Cartilage repair: TGA-approved in Australia for osteoarthritis (as i-Body)
• Category 1: Cleared under the 2026 HHS reclassification for 503A compounding

Tesamorelin — The Body Composition Optimizer

Tesamorelin takes a different approach — rather than being a GH fragment, it stimulates your pituitary to produce more endogenous growth hormone. This preserves the natural pulsatile GH pattern while elevating baseline levels, leading to enhanced lipolysis (particularly visceral fat), improved body composition, and potential cognitive benefits.

• Visceral fat reduction: Phase III trials showed ~18% trunk fat reduction
• Natural GH release: Preserves feedback mechanisms, avoiding supraphysiological levels
• Cognitive benefit: Improved executive function in older adults at Alzheimer's risk
• FDA-approved: As Egrifta for HIV-associated lipodystrophy

MOTS-C — The Exercise Mimetic

MOTS-C is a mitochondrial-derived peptide that activates AMPK — the body's master energy sensor — producing metabolic effects that parallel exercise. It improves insulin sensitivity, enhances fatty acid oxidation, and improves glucose uptake, all without requiring physical exertion. Circulating MOTS-C levels decline with age, which may partially explain age-related metabolic decline.

• AMPK activation: The same pathway activated by exercise and metformin
• Insulin sensitivity: Improved glucose homeostasis in obese animal models
• Exercise performance: Improved endurance and physical capacity in aged mice
• Category 1: Cleared under the 2026 reclassification

Stacking Strategies for Fat Loss

Many researchers explore combinations: AOD-9604 for direct lipolysis + MOTS-C for metabolic optimization, or Tesamorelin + a GLP-1 agonist for simultaneous GH-mediated recomposition and appetite control. The key distinction is that AOD-9604 and MOTS-C are particularly suited for people who want to lose fat without the appetite suppression and GI effects of GLP-1s, or who want to maintain lean mass more effectively during a deficit.

Source Fat Loss Research Peptides

Related Peptide Profiles